ScellCare

ScellCare encompasses the collection of umbilical cord biosamples, processing to obtain enriched stem cell components, acquisition of progenitor cellular genomics information to generate predictive health signatures and cryopreservation of stem cell units for intended applications

The biosample collection process is non-invasive, painless, and presents no risk to the donor. The predictive health signatures provide donor-specific profiles as a report, while the cryopreserved stem cell components (Hematopoietic and Mesenchymal stem cells) have the capacity to address 40 medical conditions across over 72 potential disease targets. Stem cell genomics involves analyzing the genome of stem cells to predict predisposition to both genetic and lifestyle-related disorders. 

Clients can enroll by selecting the appropriate plan. The biosample is collected in a specialized kit and transported to our laboratory, where processing commences promptly. The received biosample undergoes testing for transmissible diseases, including HIV, Hepatitis B & C, VDRL, and MP

BioBanking Procedure